Skip to main content
Caplight Logo









Kookmin Bio Co., Ltd.

Kookmin Bio Co., Ltd.

Private
JeonjuHealthcare & Life Scienceshttps://kmbio.co.kr/ko/

Last Round

Series B

Nov 20, 2024

Total Funding Raised

$4.58M

Company Overview

Kookmin Bio Co., Ltd. is a biotechnology company that researches and develops bio-based food and pharmaceutical ingredients and microbiome-based new drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, D2C Brands, Sports & Fitness

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

postbioticsmicrobiome modulationfunctional foodsnutraceuticalssarcopenia treatmentobesity treatmentmicrobiome therapeuticsdrug discoverygut healthB2B ingredientsfermentation technologybiopharmaKorean fermented foodsclinical trialshealth functional foodsGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kookmin Bio Co., Ltd. Comparables

Compare Kookmin Bio Co., Ltd. with similar companies based on industry and business-model similarity.

Kookmin Bio Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genome & Company
66%
Chong Kun Dang Holdings Corp.
65%
hy
60%

Kookmin Bio Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 20, 2024
Series AMay 20, 2022
Pre SeedNov 19, 2021

Kookmin Bio Co., Ltd. Investors

Notable investors and investment history

Kookmin Bio Co., Ltd. investors
InvestorRounds
Korea Alternative Asset ManagementSeries A, Series B
K-Ground VenturesSeries B
Kookmin University Technology Holding Co., Ltd.Series A
New Paradigm InvestmentSeries A, Series B, Pre Seed
Industrial Bank of KoreaSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2024

    $3M round led by New Paradigm Investment.

  • May 20, 2022

    $1.58M round led by New Paradigm Investment.

Kookmin Bio Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Kookmin Bio Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kookmin Bio Co., Ltd.'s valuation, stock price, and market status.

Is Kookmin Bio Co., Ltd. a public or private company?

Kookmin Bio Co., Ltd. is a private company.

What is the current stock price of Kookmin Bio Co., Ltd.?

Kookmin Bio Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Kookmin Bio Co., Ltd. worth (valuation)?

Valuation information for Kookmin Bio Co., Ltd. is not publicly available.

Can I buy Kookmin Bio Co., Ltd. stock?

Kookmin Bio Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kookmin Bio Co., Ltd.'s last funding round?

Kookmin Bio Co., Ltd.'s most recent funding round was Series B on November 20, 2024.

Who are the main investors in Kookmin Bio Co., Ltd.?

Key investors in Kookmin Bio Co., Ltd. include New Paradigm Investment.

Will Kookmin Bio Co., Ltd. IPO soon?

No public IPO plans have been announced for Kookmin Bio Co., Ltd..

How can I track Kookmin Bio Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kookmin Bio Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJeonju
Year Founded2019
Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?